Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: An autopsy study

Atherosclerosis

Volumn 171, Issue 1, 2003, Pages 31-37

  Rontu, Riikka ^a,b   Karhunen, Pekka J ^b   Ilveskoski, Erkki ^a,b   Mikkelsson, Jussi ^b   Kajander, Olli ^b   Perola, Markus ^c   Penttilä, Antti ^d   Koivisto, Anna Maija ^e   Lehtimäki, Terho ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Autopsy study; Coronary artery disease; Genetics; Paraoxonase 1; Smoking

Indexed keywords

FAT;

ABDOMINAL AORTA; ADULT; AGED; AORTA; ARTICLE; AUTOPSY; CIGARETTE SMOKING; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; FIBROSIS; FINLAND; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARAOXONASE 1 GENE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THORACIC AORTA;

EID: 0344420101     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.07.002     Document Type: Article

References (35)

1. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Eng. J. Med. 320:1989;915-924.
3. Heitzer T., Yla-Herttuala S., Luoma J.et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 93:1996;1346-1353.
4. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
5. Watson A.D., Berliner J.A., Hama S.Y., La Bu B.N., Faull K.F., Fogelman A.M.et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
6. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
7. Aviram M., Hardak E., Vaya J.et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation. 101:2000;2510-2517.
8. Tward A., Xia Y.R., Wang X.P.et al. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation. 106:2002;484-490.
9. Rozenberg O., Rosenblat M., Coleman R., Shih D.M., Aviram M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med. 34:2003;774-784.
10. Furlong C.E., Costa L.G., Hassett C.et al. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem. Biol. Interact. 87:1993;35-48.
11. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 423:1998;57-60.
12. Garin M.C., James R.W., Dussoix P.et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme: a possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest. 99:1997;62-66.
13. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:2001;473-480.
14. Gardemann A., Philipp M., Hess K., Katz N., Tillmanns H., Haberbosch W. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis. 152:2000;421-431.
15. Sanghera D.K., Saha N., Kamboh M.I. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian, Indians and Chinese. Atherosclerosis. 136:1998;217-223.
16. Zama T., Murata M., Matsubara Y.et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler. Thromb. Vasc. Biol. 17:1997;3565-3569.
17. Salonen J.T., Malin R., Tuomainen T.P., Nyyssonen K., Lakka T.A., Lehtimaki T. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. Br. Med. J. 319:1999;487-489.
18. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
19. Guzman M.A., McMahan C.A., McGill H.C. Jr.et al. Selected methodologic aspects of the International Atherosclerosis Project. Lab. Invest. 18:1968;479-497.
20. Uemura K., Sternby N., Vanecek R., Vihert A., Kagan A. Grading atherosclerosis in aorta and coronary arteries obtained at autopsy. Bull. Wld. Hlth. Org. 31:1964;297-320.
21. Malin R., Rantalaiho V., Huang X.H.et al. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects. Hum. Genet. 105:1999;179-180.
22. Leviev I., Negro F., James R.W. Two alleles of the human paraoxonase gene produce different amounts of mRNA: an explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler. Thromb. Vasc. Biol. 17:1997;2935-2939.
23. Mackness B., Hunt R., Durrington P.N., Mackness M.I. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;1233-1238.
24. Rosenblat M., Draganov D., Watson C.E., Bisgaier C.L., La Du B.N., Aviram M. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23:2003;468-474.
25. Rozenberg O., Shih D.M., Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2- like activity and lysophosphatidylcholine formation. Arterioscler. Thromb. Vasc. Biol. 23:2003;461-467.
26. Malin R., Jarvinen O., Sisto T., Koivula T., Lehtimaki T. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. Atherosclerosis. 157:2001;301-307.
27. Mackness B., Davies G.K., Turkie W.et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol. 21:2001;1451-1457.
28. Nishio E., Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem. Biophys. Res. Commun. 236:1997;289-293.
29. Sen-Banerjee S., Siles X., Campos H. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 20:2000;2120-2126.
30. Pfohl M., Koch M., Enderle M.D.et al. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes. 48:1999;623-627.
31. Malin R., Loimaala A., Nenonen A.et al. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism. 50:2001;1095-1101.
32. McGill H.C. Jr., McMahan C.A., Herderick E.E., Malcom G.T., Tracy R.E., Strong J.P. Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 72:2000;1307S-1315S.
33. Leviev I., James R.W. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol. 20:2000;516-521.
34. Karhunen P.J., Penttila A. Validity of post-mortem alcohol reports. Alcohol Alcohol. 25:1990;25-32.
35. Donato F., Boffetta P., Fazioli R., Gelatti U., Porru S. Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study. Eur. J. Epidemiol. 14:1998;259-267.